XTL Biopharmaceuticals Ltd.

XTLB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.38

-$0.02 (-0.83%)

At close: Sep 21, 2026, 4:00 PM ET

$2.22

-$0.16 (-6.72%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.83%

(1D)

Rating

Updated: Aug 21, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.25M

1D Range

2.19 2.38

52W Range

2.01 10.28

Valuation (TTM)

PE -0.83

PB -8.86

EV/EBITDA -3.00

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield 0.0%

SBC Adj. FCF Yield -11.7%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin -481.6%

FCF Margin 0.0%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | 100.0%

Dil EPS 3Y | 5Y 13.8% | 2.5%

FCF 3Y | 5Y -14.0% | -6.8%

Returns

ROA -4198.2%

ROE -269.0%

ROIC -11253.3%

Financial Health

Net Debt

$125K

Current Ratio 0.40

Interest Coverage -241.14

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to...

Sector Healthcare

Industry Biotechnology

Employees 10

IPO Date Aug 31, 2005

Website www.xtlbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.